✦ LIBER ✦

Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival

✍ Scribed by Philipp Schütt; Peter Ebeling; Ulrike Buttkereit; Dieter Brandhorst; Bertram Opalka; Miriam Poser; Siemke Müller; Michael Flasshove; Thomas Moritz; Siegfried Seeber; Mohammad Resa Nowrousian

Publisher: Springer
Year: 2005
Tongue: English
Weight: 132 KB
Volume: 84
Category: Article
ISSN: 0939-5555
DOI: 10.1007/s00277-005-1007-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Soluble interleukin-2 receptor serum lev

Soluble interleukin-2 receptor serum level as a predictor of locoregional control and survival for patients with head and neck carcinoma : Results of a multivariate prospective study

✍ Eric Tartour; Laurent Deneux; Veronique Mosseri; Christian Jaulerry; Françoise B 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 106 KB 👁 3 views

Jose ´Rodriguez, M.D. ## RESULTS. At presentation, a relationship was observed between advanced tumor (T) classification and high serum levels of CRP (P Å 0.0015) and s-IL-2-R (P õ Head and